Results 221 to 230 of about 22,592,545 (351)

Towards an international research agenda for public health advocacy: Practice, preparedness and knowledge gaps. [PDF]

PLOS Glob Public Health
Cullerton K, D'cunha K, Clifford Astbury C, Hunt D, Bhatti AJ, Aryeetey R.   +5 more
europepmc   +1 more source

Publication

Discours d’Europe, 2018
openaire   +3 more sources

HousingWorks RI: Residential Foreclosure Deeds Continue to Fall in R.I. [PDF]

, 2016
Public Affairs, Roger Williams University
core   +1 more source

Frailty Exacerbates Disability in Progressive Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks, Anna Wolska, Diala Ghazal, Dejan Jakimovski, Bianca Weinstock‐Guttman, Alexander Burnham, Niels Bergsland, Michael G. Dwyer, Alan T. Remaley, Robert Zivadinov, Murali Ramanathan   +10 more
wiley   +1 more source

A word from the editor. [PDF]

J Public Health Res
Balinska MA.
europepmc   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Our greatest untapped resource

The Lancet Public Health, 2017
The Lancet Public Health
doaj   +1 more source

Public health actions in response to pathogen detection in wastewater and the environment: a scoping review. [PDF]

Front Public Health
de Jong M, de Korne-Elenbaas J, Fanoy E, Medema G, de Graaf M, Prins M, van der Loeff MFS, Daams J, Husman AMR, Heijne JCM.   +9 more
europepmc   +1 more source

Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte, Lucy Norcliffe‐Kaufmann, Maria Luisa Cotrina, Zenith Khan, Kaia Dalamo, Patricio Millar Vernetti, Matthew Lawless, Elisabetta Morini, Monica Salani, Marla Weetall, Jana Narasimhan, Agostino G. Rocha, Susan A. Slaugenhaupt, Horacio Kaufmann   +13 more
wiley   +1 more source